Search
for
Sort by
Research 151–180 of 324
- Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence
- Oral Presentations
- Subject Index
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Exploring Pediatric Dermatology in Skin of Color: Focus on Dermoscopy
- Medical Dermatology
- Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Malassezia infection: is there any chance or necessity in refractory acne?
- Cosmetic adverse effects of antiseizure medications; A systematic review
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Development, Optimization, and In Vitro/In Vivo Evaluation of Azelaic Acid Transethosomal Gel for Antidermatophyte Activity
- Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
- Acne Vulgaris
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- Rosacea: I. Etiology, pathogenesis, and subtype classification
- Isotretinoin treatment of acne and related disorders: An update
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Azelaic Acid: Mechanisms of Action and Clinical Applications
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Dermoscopic spectrum of rosacea
- Atypical folliculitis caused by Malassezia spp. in immunosuppressed patients
- The management and treatment of acne
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Use of Plasma-Rich in Growth Factors (PRGF) in the Treatment of Acne